Skip to main content

Tooth Extraction

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Osteo-Pharma
Osteo-PharmaNetherlands - Oss
1 program
XenograftN/A1 trial
Active Trials
NCT02952209Unknown15Est. Dec 2021
Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
Xenograft bone substituteN/A1 trial
Active Trials
NCT02844569Completed24Est. Feb 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Osteo-PharmaXenograft
Geistlich PharmaXenograft bone substitute

Clinical Trials (2)

Total enrollment: 39 patients across 2 trials

The Effect of Alveolar Ridge Preservation After Tooth Extraction in the Posterior Maxilla

Start: Sep 2016Est. completion: Dec 202115 patients
N/AUnknown
NCT02844569Geistlich PharmaXenograft bone substitute

A Volumetric Analysis of Soft and Hard Tissue Healing for Ridge Preservation and Socket Seal After Tooth Extraction

Start: Jul 2016Est. completion: Feb 201824 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.